EA200501262A1 - Композиция с пролонгированным высвобождением венлафаксина - Google Patents
Композиция с пролонгированным высвобождением венлафаксинаInfo
- Publication number
- EA200501262A1 EA200501262A1 EA200501262A EA200501262A EA200501262A1 EA 200501262 A1 EA200501262 A1 EA 200501262A1 EA 200501262 A EA200501262 A EA 200501262A EA 200501262 A EA200501262 A EA 200501262A EA 200501262 A1 EA200501262 A1 EA 200501262A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prolonged
- venlafaxin
- issues
- composition
- venlafaxine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к таблетированным композициям с пролонгированным высвобождением венлафаксина. Показано, что Коллидон SR является превосходным агентом для пролонгированного высвобождения венлафаксина, который является чрезвычайно растворимым лекарством.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IS6710A IS6710A (is) | 2003-02-07 | 2003-02-07 | Venlafaxín samsetningar með seinkaða losun |
IS7143A IS7143A (is) | 2004-02-05 | 2004-02-05 | Venlafaxín samsetningar með seinkaða losun |
PCT/IS2004/000003 WO2004069228A2 (en) | 2003-02-07 | 2004-02-09 | Sustained release formulations of venlafaxine |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200501262A1 true EA200501262A1 (ru) | 2006-04-28 |
EA011579B1 EA011579B1 (ru) | 2009-04-28 |
Family
ID=32852478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501262A EA011579B1 (ru) | 2003-02-07 | 2004-02-09 | Композиция с пролонгированным высвобождением венлафаксина |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060246132A1 (ru) |
EP (1) | EP1596837A2 (ru) |
EA (1) | EA011579B1 (ru) |
IS (1) | IS8011A (ru) |
NO (1) | NO20054157L (ru) |
WO (1) | WO2004069228A2 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2507685A1 (en) * | 2002-11-28 | 2004-06-10 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
CZ20033294A3 (cs) * | 2003-12-03 | 2005-06-15 | Zentiva, A.S. | Potahovaná tableta s obsahem venlafaxinu nebo jeho solí s řízeným uvolňováním |
DE602004006443T2 (de) * | 2004-02-04 | 2008-01-10 | Alembic Ltd., Vadodara | Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung |
US20090175934A1 (en) * | 2006-03-08 | 2009-07-09 | Jubilant Organosys Ltd. | Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
CZ307916B6 (cs) * | 2017-05-08 | 2019-08-21 | mcePharma s. r. o. | Orodispergovatelná tableta s biodostupným kurkuminem a její použití |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
CA2395333C (en) * | 1999-12-23 | 2009-01-13 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
AU2002217373A1 (en) * | 2002-01-03 | 2003-07-15 | Lek Pharmaceutical And Chemical Company D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
WO2003082806A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Venlafaxine base |
IL149055A0 (en) * | 2002-04-09 | 2002-11-10 | Karma Pharm Ltd | Extended release composition comprising as active compound venlafaxine hydrochloride |
-
2004
- 2004-02-09 US US10/544,624 patent/US20060246132A1/en not_active Abandoned
- 2004-02-09 EA EA200501262A patent/EA011579B1/ru unknown
- 2004-02-09 EP EP04709317A patent/EP1596837A2/en not_active Withdrawn
- 2004-02-09 WO PCT/IS2004/000003 patent/WO2004069228A2/en active Application Filing
-
2005
- 2005-09-06 IS IS8011A patent/IS8011A/is unknown
- 2005-09-07 NO NO20054157A patent/NO20054157L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA011579B1 (ru) | 2009-04-28 |
US20060246132A1 (en) | 2006-11-02 |
WO2004069228A3 (en) | 2004-09-16 |
NO20054157D0 (no) | 2005-09-07 |
WO2004069228A2 (en) | 2004-08-19 |
NO20054157L (no) | 2005-11-03 |
EP1596837A2 (en) | 2005-11-23 |
IS8011A (is) | 2005-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018003398A1 (es) | Composición farmacéutica de liberación sostenida que comprende micro-partículas. (divisional de solicitud 2013-03538). | |
MX2020007479A (es) | Profármacos de ketamina, composiciones y usos de los mismos. | |
NO20171811A1 (no) | Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol | |
CR10157A (es) | Compuestos químicos | |
NL2000281A1 (nl) | Vaste farmaceutische samenstellingen die pregabaline bevatten. | |
CL2017000669A1 (es) | Forma de dosificación farmacéutica (divisional de la solicitud 1029/2014) | |
AR052238A1 (es) | Formulacion de tabletas estables | |
AR055441A1 (es) | Formulacion novedosa | |
TW200716119A (en) | A solid pharmaceutical dosage formulation | |
UY28745A1 (es) | Nuevos compuestos | |
BRPI0509184A (pt) | composições farmacêuticas | |
CL2008001024A1 (es) | Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras | |
WO2006119498A3 (en) | Pharmaceutical compositions with synchronized solubilizer release | |
MEP3608A (en) | Modified-release tablet of bupropion hydrochloride | |
GT200400239A (es) | Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente | |
UY30472A1 (es) | Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones. | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
GT200600194A (es) | Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada | |
UY30319A1 (es) | Formulaciones de inhibidores de dpp iv | |
BRPI0518904A2 (pt) | formulaÇÕes de nepafenac tàpicas | |
CY1122416T1 (el) | Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης | |
BRPI0620229A8 (pt) | formulação | |
BR122016006880B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
TW200640932A (en) | Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |